Clinical Trial

The Effect of Transcutaneous Electrical Nerve Stimulation in Patients After Retrograde Intrarenal Surgery

Study acronym: RIRS TENS
Completed
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the effects of Transcutaneous Electrical Nerve Stimulation (TENS) on pain, nausea, vomiting, and quality of recovery in patients undergoing Retrograde Intrarenal Surgery (RIRS). This prospective, randomized controlled trial, designed as a two-group study, will be conducted at the Department of Urology, Yozgat Bozok University Health Practice and Research Center between September 2025 and September 2026. A total of 72 patients who underwent RIRC and met the inclusion criteria will be included in the study. Participants will be randomly divided into two groups: an intervention group receiving TENS (n=36) and a control group without TENS (n=36). Pain levels, frequency of nausea and vomiting, and quality of recovery in both groups will be compared within the first 24 hours postoperatively. This study is expected to provide evidence-based data on the effectiveness of TENS, a non-pharmacological method, in symptom management after RIRS.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-08
notable Primary completion moved earlier: 2026-05-01 -> 2025-12-01 2026-07-08
minor Completion moved earlier: 2026-12-01 -> 2026-05-01 2026-07-08
Trial Details
NCT Number NCT07405502
Lead Sponsor Bozok University
Conditions Urinary Calculus
Enrollment 72 participants
Start Date 2025-08-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07